Chondroprotective tripeptide bioregulator (Ala-Glu-Asp) that activates chondrogenic differentiation through SOX9/COL2A1/aggrecan upregulation, reverses senescence-associated secretory phenotype in aging chondrocytes, and provides geroprotective effects through SIRT-6 upregulation and p16/p21/p53 suppression
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Oral (capsule)
Route
1 recommended
Sites
Once daily
Frequency
Preparation
Cartalax in its prescribed form
Clean, dry storage container
Measuring device if applicable (oral syringe, measuring cup)
Calendar or reminder app for dosing schedule
Pro tip
Prepare all supplies on a clean surface before you begin. Having everything ready makes the process smoother and more sterile.
Mixing
Example calculation
Cartalax comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.
Dose calculation
Use Cartalax exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.
Location
Site 01
Not applicable—this is not an injectable formulation
Follow your provider's instructions for this injection site. Rotate sites regularly to prevent tissue damage.
Rotate between 1 sites to prevent tissue buildup and ensure consistent absorption.
Pro tip
Rotate your injection sites with each dose to prevent lipohypertrophy (buildup of fatty tissue). Keep a simple log of where you last injected.
Step by step
Follow the specific administration instructions for your Cartalax formulation
Take or apply as directed by your healthcare provider
Store properly between uses according to package instructions
Pro tip
This peptide uses cartalax is administered oral (capsule)—no injection required. Inject at a 90 degree angle into the muscle. Aspirate before injecting to ensure you haven't hit a blood vessel.
Timing
Optimal timing
Best time
Take Cartalax at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.
With food?
Cartalax can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.
Stacking notes
Cartalax should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Oral (capsule)—rotate sites if applicable
Maintain a consistent schedule for optimal results with Cartalax. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Dosing tiers
Dose
200 mcg
Frequency
Once daily
Duration
10-day cycles, repeated periodically
Cartalax has only lab and cell-culture research, so there is no trial-set human dose. In practice it is commonly given as 200 mcg daily in short 10-day cycles, matching how other Khavinson short peptides are used [3][4].
Preservation
Before mixing
Store Cartalax in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After mixing
Once reconstituted, Cartalax should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Shelf life after mixing
10 days refrigerated (solution form); capsules stable for 2-3 years in original packaging
Signs of degradation
Discard the vial immediately if you notice any of these:
Solution appears cloudy, discolored, or contains visible particles (should be clear)
Product has been exposed to temperatures outside the recommended storage range
Product has been frozen (unless specifically designed for freeze-thaw stability)
Expiration date has passed or reconstituted solution has exceeded its use-by date
Unusual odor, color change, or visible contamination
Important
When to stop
Severe or worsening side effects that don't improve with dose adjustment or supportive care
Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
Your healthcare provider recommends discontinuation based on your clinical response
Development of any new medical condition that may be contraindicated with Cartalax
Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
Abnormal lab results or clinical markers that suggest adverse effects
Cartalax should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Clean technique checklist
Wash hands thoroughly with soap and water before handling supplies
Swab vial tops and injection site with alcohol and let dry
Never touch the needle tip or allow it to contact non-sterile surfaces
Use a new syringe and needle for each injection
Dispose of used sharps in a proper sharps container
Store reconstituted peptides according to the storage instructions above
Published research
Myakisheva SN, Linkova NS, Diatlova AS · 2023
Cartilage-building peptides like cartalax activate chondrocytes and boost collagen production, helping stem cells repair damaged joint cartilage and potentially treating osteoarthritis.
Myakisheva SN, Linkova NS, Kozhevnikova EO · 2023
Research (2023) on cartalax contributes important scientific knowledge about its biological and pharmacological properties.
Linkova N, Khavinson V, Diatlova A · 2023
Research (2023) on cartalax contributes important scientific knowledge about its biological and pharmacological properties.
Ashapkin V, Khavinson V, Shilovsky G · 2020
Research (2020) on cartalax contributes important scientific knowledge about its biological and pharmacological properties.
Khavinson VKh, Tarnovskaia SI, Lin'kova NS · 2014
Research (2014) on cartalax contributes important scientific knowledge about its biological and pharmacological properties.
Head to head